Paclitaxel‐coated balloon in the treatment of recurrent dysfunctional arteriovenous access, real‐world experience and longitudinal follow up

ABSTRACT Aim Dysfunctional arteriovenous (AV) access remains a significant cause of morbidity and hospital admission for patients with end stage renal failure on haemodialysis. This study was performed to evaluate the impact of paclitaxel‐coated Balloon (PCB) on the patency of AV access with recurre...

Full description

Saved in:
Bibliographic Details
Published in:Nephrology (Carlton, Vic.) Vic.), 2019-12, Vol.24 (12), p.1290-1295
Main Authors: Phang, Chee Chin, Tan, Ru Yu, Pang, Suh Chien, Tan, Chee Wooi, Teh, Swee Ping, Cheng, Rui‐Wern, Kho, Yu Xuan, Chong, Tze Tec, Gogna, Apoorva, Foo, Wai Yin, Tan, Chieh Suai
Format: Article
Language:English
Subjects:
Angioplasty
Angioplasty, Balloon - adverse effects
Angioplasty, Balloon - methods
Antineoplastic Agents, Phytogenic - pharmacology
arteriovenous fistula
arteriovenous graft
Arteriovenous Shunt, Surgical - adverse effects
Arteriovenous Shunt, Surgical - methods
Coated Materials, Biocompatible - pharmacology
Female
Fistula
Fistulae
haemodialysis
Hemodialysis
Humans
Intervention
Kidney Failure, Chronic - therapy
Male
Middle Aged
Morbidity
Paclitaxel
Paclitaxel - pharmacology
paclitaxel‐coated balloon
Patients
PCB
Polychlorinated biphenyls
Postoperative Complications - prevention & control
Renal Dialysis - adverse effects
Renal Dialysis - instrumentation
Renal Dialysis - methods
Renal failure
Reoperation - methods
Reoperation - statistics & numerical data
Survival analysis
thrombolysis
Thrombosis - etiology
Thrombosis - prevention & control
Treatment Outcome
Vascular Access Devices
Vascular Grafting - adverse effects
Vascular Grafting - methods
Vascular Patency
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Aim Dysfunctional arteriovenous (AV) access remains a significant cause of morbidity and hospital admission for patients with end stage renal failure on haemodialysis. This study was performed to evaluate the impact of paclitaxel‐coated Balloon (PCB) on the patency of AV access with recurrent stenoses. Methods We retrospectively studied haemodialysis patients who presented to our centre with recurrent AV access dysfunction and compared intervention‐free patency using plain balloon versus PCB. Results A total of 147 patients were followed up longitudinally. Intervention‐free patency was better following PCB compared to previous intervention using plain balloons (6.4 ± 5.8 versus 4.0 ± 3.7, P 
ISSN:1320-5358
1440-1797
DOI:10.1111/nep.13591